Critical Shortage of Veterinarians Requires Congressional Investment
11 mars 2010 10h29 HE
|
Association of American Veterinary Medical Colleges
WASHINGTON, DC--(Marketwire - March 11, 2010) - Officials from the nation's 28 colleges of
veterinary medicine converged on Capitol Hill today to advocate for HR2999,
The Veterinary Public Health...
Shifting Societal Needs and Changes to Professional Competencies Assessed by Over 100 Veterinary Leaders at First NAVMEC Meeting
16 févr. 2010 13h51 HE
|
Association of American Veterinary Medical Colleges
LAS VEGAS, NV--(Marketwire - February 16, 2010) - One of the most diverse representations of
veterinary organizations ever assembled completed three days of meetings on
Saturday to begin a year-long...
Marshall Edwards, Inc.'s Action Intended to Regain Compliance With Nasdaq Share Price Rule, Benefit Shareholders
09 févr. 2010 15h30 HE
|
Marshall Edwards, Inc.
NEW CANAAN, CT--(Marketwire - February 9, 2010) - Marshall Edwards, Inc. (NASDAQ: MSHL), a specialist oncology company focusing on the clinical development of novel anti-cancer therapeutics,...
Marshall Edwards, Inc. Announces Resignation of Christopher Naughton From Board of Directors
08 févr. 2010 08h00 HE
|
Marshall Edwards, Inc.
SYDNEY, AUSTRALIA--(Marketwire - February 8, 2010) - Marshall Edwards, Inc. (NASDAQ: MSHL)
announced that Christopher Naughton had resigned as a member of the Board
of Directors effective February 5,...
Analysis of Marshall Edwards, Inc.'s OVATURE Trial to Proceed Following Database Lock
21 janv. 2010 18h34 HE
|
Marshall Edwards, Inc.
NEW CANAAN, CT--(Marketwire - January 21, 2010) - The Board of Directors of Marshall Edwards,
Inc. today advised that analysis of tumor response data from the OVATURE
trial will be performed in the...
Marshall Edwards, Inc. Appoints Acting CEO
01 déc. 2009 00h01 HE
|
Marshall Edwards, Inc.
SYDNEY, AUSTRALIA and NEW CANAAN, CT--(Marketwire - December 1, 2009) - Novogen Limited
advises that CEO and Managing Director Christopher Naughton will cease his
employment with the Company from...
The AIDS Institute, Nobel Prize Winner Join on World AIDS Day to Call for More Therapeutic Vaccine Funding
25 nov. 2009 14h08 HE
|
The AIDS Institute
WASHINGTON, DC--(Marketwire - November 25, 2009) - In honor of World AIDS Day, The AIDS
Institute (TAI), one of the nation's leading advocacy organizations for
support of people with HIV/AIDS and...
Researchers Find That Vacc-4x Therapeutic Peptide-Based HIV Vaccine Increases CD4 T-Cells in Chronically Infected HIV-1 Patients on Antiretroviral Therapy (ART)
21 oct. 2009 08h00 HE
|
Bionor Immuno
PARIS--(Marketwire - October 21, 2009) - EMBARGOED FOR RELEASE UNTIL 2:00pm CEST, or 8:00am
USA EST -- Abstract #173886 -- An immunological analysis of a Phase II
clinical trial demonstrated that the...
Bionor Immuno Welcomes Renowned Virologist Robert Redfield, MD to Its Clinical Advisory Board
19 oct. 2009 10h00 HE
|
Bionor Immuno
BETHESDA, MD and OSLO, NORWAY and PARIS--(Marketwire - October 19, 2009) - Bionor Immuno
announced today at the AIDS Vaccine 2009 conference in Paris, France, that
Robert Redfield, MD, Associate...
Marshall Edwards, Inc.'s NV-128, a Novel mTOR Inhibitor, Demonstrates Good Safety Profile and High Anti-Cancer Activity In Vivo
29 sept. 2009 08h30 HE
|
Marshall Edwards, Inc.
SYDNEY, AUSTRALIA and NEW CANAAN, CT--(Marketwire - September 29, 2009) - Marshall Edwards, Inc.
(NASDAQ: MSHL), a pharmaceutical company specializing in clinical
development of oncology drugs, today...